scholarly journals Histone Deacetylase Sirtuin 1 Deacetylates IRF1 Protein and Programs Dendritic Cells to Control Th17 Protein Differentiation during Autoimmune Inflammation

2013 ◽  
Vol 288 (52) ◽  
pp. 37256-37266 ◽  
Author(s):  
Heeyoung Yang ◽  
Sang-Myeong Lee ◽  
Beixue Gao ◽  
Jinping Zhang ◽  
Deyu Fang
2021 ◽  
Vol 97 ◽  
pp. 107698
Author(s):  
Chunlei Feng ◽  
Lingyun Li ◽  
Qing Li ◽  
Kirsten Switzer ◽  
Mingyao Liu ◽  
...  

2016 ◽  
Vol 9 (2) ◽  
pp. 126-144 ◽  
Author(s):  
Yaping Sun ◽  
Matthew Iyer ◽  
Richard McEachin ◽  
Meng Zhao ◽  
Yi-Mi Wu ◽  
...  

STAT3 is a master transcriptional regulator that plays an important role in the induction of both immune activation and immune tolerance in dendritic cells (DCs). The transcriptional targets of STAT3 in promoting DC activation are becoming increasingly understood; however, the mechanisms underpinning its role in causing DC suppression remain largely unknown. To determine the functional gene targets of STAT3, we compared the genome-wide binding of STAT3 using ChIP sequencing coupled with gene expression microarrays to determine STAT3-dependent gene regulation in DCs after histone deacetylase (HDAC) inhibition. HDAC inhibition boosted the ability of STAT3 to bind to distinct DNA targets and regulate gene expression. Among the top 500 STAT3 binding sites, the frequency of canonical motifs was significantly higher than that of noncanonical motifs. Functional analysis revealed that after treatment with an HDAC inhibitor, the upregulated STAT3 target genes were those that were primarily the negative regulators of proinflammatory cytokines and those in the IL-10 signaling pathway. The downregulated STAT3-dependent targets were those involved in immune effector processes and antigen processing/presentation. The expression and functional relevance of these genes were validated. Specifically, functional studies confirmed that the upregulation of IL-10Ra by STAT3 contributed to the suppressive function of DCs following HDAC inhibition.


2015 ◽  
Vol 18 (4) ◽  
pp. 713 ◽  
Author(s):  
Jody K Takemoto ◽  
Connie M. Remsberg ◽  
Neal M. Davies

Purpose: Delineate the selected pharmacodynamics of a naturally occurring stilbene 3’-Hydroxypterostilbene. Objective: Characterize for the first time the pharmacodynamics bioactivity in several in-vitro assays with relevant roles in heart disease, inflammation, cancer, and diabetes etiology and pathophysiology. Methods: 3’-Hydroxypterostilbene was studied in in-vitro assays to identify possible bioactivity. Results: 3’-Hydroxypterostilbene demonstrated anti-oxidant, anti-inflammatory, cytotoxic, anti-adipogenic, histone deacetylase, and sirtuin-1 inhibitory activity. Conclusions: The importance of understanding individual stilbene pharmacologic activities were delineated.  Small changes in chemical structure of stilbene compounds result in significant pharmacodynamic differences. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.


Author(s):  
Laleh Heidari ◽  
Sayyed Mohammad Hossein Ghaderian ◽  
Milad Bastami ◽  
Shadi Hosseini ◽  
Saeed Alipour Parsa ◽  
...  

2019 ◽  
Vol 203 (10) ◽  
pp. 2602-2613 ◽  
Author(s):  
Nico Andreas ◽  
Maria Potthast ◽  
Anna-Lena Geiselhöringer ◽  
Garima Garg ◽  
Renske de Jong ◽  
...  

2015 ◽  
Vol 173 (3) ◽  
pp. 545-561 ◽  
Author(s):  
Jing Chen ◽  
Jinsheng Lai ◽  
Lei Yang ◽  
Guoran Ruan ◽  
Sandip Chaugai ◽  
...  

2012 ◽  
Vol 13 (2) ◽  
pp. 152-161 ◽  
Author(s):  
Gonghua Huang ◽  
Yanyan Wang ◽  
Peter Vogel ◽  
Thirumala-Devi Kanneganti ◽  
Kinya Otsu ◽  
...  

2011 ◽  
Vol 187 (9) ◽  
pp. 4517-4529 ◽  
Author(s):  
Agnieszka Legutko ◽  
Thomas Marichal ◽  
Laurence Fiévez ◽  
Denis Bedoret ◽  
Alice Mayer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document